Windlas Biotech vs Alembic business model compares concentrated domestic contract manufacturing for branded generics against diversified branded generics manufacturing across multiple therapeutic categories to see which contract and branded formulations has better business model.

ABSL Liquid Regular IDCW NAV, latest returns and full review including risks and how to invest.

Alembic vs Mankind Pharma business model compares diversified branded generics manufacturing across multiple therapeutic categories against scale-led domestic branded generics combined with consumer healthcare products to see which domestic branded formulations has better business model.

Wall Street today closed lower as the Nasdaq led declines with mixed technology earnings, while investors awaited key reports amid a rally fed by AI enthusiasm.

ABSL Floating Rate Direct Growth NAV, latest returns and full review including risks and how to invest.

ABSL Medium Term Plan Regular IDCW NAV, latest returns and full review including risks and how to invest.

JSW Energy share price target is Rs 549 after CLSA retained its hold rating following a 37 percent YoY PAT decline in Q1 FY27 on higher funding costs and tariff cuts.